Search results
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American biochemist who specializes in ribonucleic acid -mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy.
Dr. Kariko is a researcher who co-discovered the mRNA technology used in COVID-19 vaccines. She is a senior vice president at BioNTech and an adjunct professor of Neurosurgery at the University of Pennsylvania.
Oct 2, 2023 · The Penn mRNA vaccine research team is recognized for their foundational discoveries that enabled the development of COVID-19 vaccines. They are the 28th and 29th Nobel laureates affiliated with Penn and the 61st woman to ever receive the prize in Physiology or Medicine.
Oct 1, 2021 · Katalin Kariko is an adjunct professor of neurosurgery at Penn Medicine and a pioneer of mRNA therapy. She co-discovered the nucleoside modifications that reduce RNA immunogenicity and led to the development of COVID-19 vaccines.
Apr 8, 2021 · Now Katalin Kariko, 66, known to colleagues as Kati, has emerged as one of the heroes of Covid-19 vaccine development. Her work, with her close collaborator, Dr. Drew Weissman of the University...
Oct 2, 2023 · Karikó, a Hungarian-born biochemist at Szeged University, and Drew Weissman, an immunologist at UPenn, discovered how to deliver mRNA into cells without triggering an immune response. Their breakthrough enabled the development of COVID-19 vaccines and opened a new chapter for medicine.
People also ask
When was Katalin Karikó's autobiography published?
Who is Dr Karikó?
Where did Katalin Karikó donate her Nobel Prize?
Where did Karikó get her PhD?
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
